Cargando…
Alemtuzumab-associated diffuse alveolar damage – a case report
BACKGROUND: Identifying causes of alemtuzumab induced respiratory symptoms in Multiple Sclerosis (MS) patients is crucial. CASE PRESENTATION: We report a case of diffuse alveolar damage (DAD) in a patient with MS after the first course of alemtuzumab treatment. A 42-year-old female developed progres...
Autores principales: | Bayas, Antonios, Menacher, Martina, Schwaiblmair, Martin, Märkl, Bruno, Naumann, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510011/ https://www.ncbi.nlm.nih.gov/pubmed/32967641 http://dx.doi.org/10.1186/s12883-020-01934-7 |
Ejemplares similares
-
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases
por: Rau, Daniela, et al.
Publicado: (2015) -
Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination
por: Bayas, Antonios, et al.
Publicado: (2021) -
Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
por: Myro, Aija Zuleron, et al.
Publicado: (2018) -
Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature
por: Christ, Monika, et al.
Publicado: (2019) -
Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report
por: Müller, Mona Klara Ros, et al.
Publicado: (2022)